KEAP1 and cancer: Studies have shown that aberrant activation of NRF2 in cancer can promote cell proliferation, the NRF2/KEAP1 signaling pathway is significant for the regulation of autophagy and the immune system, meanwhile, it is involved in tumorigenesis by regulating metabolic reprogramming [29].